skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model

Original Research

(1927) Views  (514) Full article downloads

Authors: Weiping Ren, Renwen Zhang, Bin Wu, et al

Published Date March 2011 Volume 2011:4 Pages 29 - 38
DOI: http://dx.doi.org/10.2147/JIR.S16232

Weiping Ren1,2, Renwen Zhang4, Bin Wu1, Paul H Wooley3, Monica Hawkins4, David C Markel2
1Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA; 2Department of Orthopedic Surgery, Providence Hospital, Southfield, MI, USA; 3Orthopedic Research Institute, Wichita, Kansas; 4Stryker Orthopaedics, Mahwah, NJ, USA

Background: The development of highly vascularized and inflammatory periprosthetic tissue characterizes the progress of aseptic loosening, a major complication of joint arthroplasty. Vascular endothelial growth factor (VEGF) is an important cell signaling protein involved in angiogenesis. The purpose of this study was to investigate whether R2/Fc (a VEGF neutralizing antibody) and SU5416 (a VEGF receptor II [Flk-1] inhibitor) could ameliorate particle-induced inflammatory osteolysis in a mouse model.
Methods: Ultrahigh molecular weight polyethylene (UHMWPE) particles were introduced into established air pouches in BALB/c mice, followed by implantation of calvaria bone from syngeneic littermates. Drug treatment was started 2 weeks after bone implantation, and mice without drug treatment were included as controls. Pouch tissues were harvested 4 weeks after bone implantation for molecular and histological analysis, and implanted bone degradation was analyzed by microcomputed tomography.
Results: Exposure to UHMWPE particles induced inflammatory osteolysis, which was associated with increased expression of VEGF/Flt-1 proteins. Treatment with R2/Fc significantly improved UHMWPE particle-induced inflammatory osteolysis, and reduced the expression of VEGF/Flt-1 proteins. However, SU5416 treatment showed no effect on UHMWPE particle-induced inflammatory osteolysis.
Conclusion: Our findings indicate that VEGF signaling exerts a regulatory effect on the development of UHMWPE-induced inflammatory osteolysis, through its unique Flt-1, rather than Flk-1, receptor located on monocyte/macrophage cell lineages. These data provide a biological rationale for a VEGF/Flt-1-targeted treatment strategy, especially during the early stages of the wear debris-induced inflammatory response.

Keywords: vascular endothelial growth factor, Flt-1, osteolysis, osteoclastogenesis, R2/Fc, SU5416, animal model, wear debris




 

Other articles by Dr Weiping Ren



Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Psychological and behavioral disease during developmental age: the importance of the alliance with parents
Interleukin-1 exerts distinct actions on different cell types of the brain in vitro
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application
Characterization of the inflammatory response to four commercial bone graft substitutes using a murine biocompatibility model
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio